Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Lindsay R Wurst"'
Autor:
Nandita eBose, Anissa SH eChan, Faimola eGuerrero, Carolyn M Maristany, Richard M Walsh, Katie E Ertelt, Adria Bykowski Jonas, Keith B Gorden, Christine M Dudney, Lindsay R Wurst, Mike E Danielson, Natalie eElmasry, Andrew S Magee, Myra L Patchen, Xiaohong eQiu, John P Vasilakos
Publikováno v:
Frontiers in Immunology, Vol 4 (2013)
The immunomodulatory properties of yeast β-1,3/1,6 glucans are mediated through their ability to be recognized by human innate immune cells. While several studies have investigated binding of opsonized and unopsonized particulate β-glucans to human
Externí odkaz:
https://doaj.org/article/b7ce282968f54f0b9afc6646f7803a14
Autor:
Will Paul M, Ryan R. Langeslay, Michael E. Danielson, Lindsay R. Wurst, Vanessa A. Iiams, Andrew S. Magee
Publikováno v:
Biopolymers. 103:665-674
Scleroglucan is a β-(1,3)-glucan which is highly branched at the 6-position with a single glucose residue. Acid hydrolysis of a high molecular weight scleroglucan gave a medium molecular weight, freely soluble material. Linkage analysis by the parti
Autor:
Andrew S, Magee, Ryan R, Langeslay, Paul M, Will, Michael E, Danielson, Lindsay R, Wurst, Vanessa A, Iiams
Publikováno v:
Biopolymers. 103(12)
Scleroglucan is a β-(1,3)-glucan which is highly branched at the 6-position with a single glucose residue. Acid hydrolysis of a high molecular weight scleroglucan gave a medium molecular weight, freely soluble material. Linkage analysis by the parti
Autor:
Jamie Lowe, Ben Harrison, Kathryn A. Fraser, Richard Walsh, Nandita Bose, Mark T. Uhlik, Anissa S.H. Chan, Nadine Ottoson, Blaine Rathmann, Jeremy R. Graff, Adria Jonas, Richard D. Huhn, Steven M. Leonardo, Lindsay R. Wurst, Ross B. Fulton, Jose Iglesias, Mark A. Matson, Katie Ertelt, Takashi O Kangas, Keith B. Gorden, Xiaohong Qiu
Publikováno v:
Cancer Immunology Research. 4:B008-B008
Imprime PGG (Imprime), in combination with both tumor-targeting and anti-angiogenic antibodies, has shown promising efficacy in multiple phase 2 clinical trials. In numerous pre-clinical in vivo tumor models, Imprime also enhances the efficacy of imm
Autor:
Adria Jonas, Keith B. Gorden, Steven M. Leonardo, Anissa S.H. Chan, Xiaohong Qui, Jeremy R. Graff, Lindsay R. Wurst, Ross B. Fulton
Publikováno v:
Cancer Immunology Research. 4:A160-A160
Imprime PGG (Imprime), a soluble yeast 1,3/1,6 β-glucan, is being developed as a novel cancer immunotherapy in conjunction with anti-tumor antibodies in several cancers. In clinical studies, including randomized Phase 2 clinical trials in the 1st-li
Autor:
Michael E. Danielson, Will Paul M, Nandita Bose, John P. Vasilakos, Anissa S.H. Chan, Sonja E Nodland, Jurandir J. Dalle Lucca, Frank J. Lebeda, Megan L LeRoux, Myra L. Patchen, Lindsay R. Wurst, Christine M. Dudney
Publikováno v:
Glycobiology. 24(4)
β-Glucans possess broad immunomodulatory properties, including activation of innate immune functions such as oxidative burst activity. The differential roles of complement receptor type 3 (CR3) and Dectin-1, the known β-glucan receptors, and their
Autor:
Faimola Guerrero, Michael E. Danielson, Natalie Elmasry, Keith B. Gorden, John P. Vasilakos, Andrew S. Magee, Xiaohong Qiu, Anissa S.H. Chan, Myra L. Patchen, Carolyn M. Maristany, Richard Walsh, Kathleen E. Ertelt, Christine M. Dudney, Lindsay R. Wurst, Adria Jonas, Nandita Bose
Publikováno v:
Frontiers in Immunology, Vol 4 (2013)
Frontiers in Immunology
Frontiers in Immunology
The immunomodulatory properties of yeast β-1,3/1,6 glucans are mediated through their ability to be recognized by human innate immune cells. While several studies have investigated binding of opsonized and unopsonized particulate β-glucans to human
Autor:
Nadine Ottoson, Steven M. Leonardo, Keith B. Gorden, Adria Jonas, Peter Maimonis, Katie Ertelt, Ben Harrison, Anissa S.H. Chan, Nandita Bose, Xiaohong Qiu, Lindsay R. Wurst
Publikováno v:
Cancer Immunology Research. 4:A014-A014
Imprime PGG (Imprime), a soluble yeast 1,3/1,6 β-glucan, is being developed as a novel cancer immunotherapy in conjunction with anti-tumor antibodies in several cancers. Randomized Phase 2 clinical trials of Imprime in the 1st-line treatment of stag
Autor:
Nadine Ottoson, Adria Jonas, Xiaohong Qiu, Richard Walsh, Nandita Bose, Diane McMurray, Lindsay R. Wurst, Steven M. Leonardo, Ben Harrison, Peter Maimonis, Katie Ertelt
Publikováno v:
Cancer Immunology Research. 3:A08-A08
Imprime PGG (Imprime) is a yeast-derived beta-1,3/1,6 glucan that binds complement receptor 3 (CR3) on innate immune cells and enables these cells to exert anti-tumor activity against tumor cells that have been opsonized by iC3b following targeting b
Publikováno v:
Cancer Research. 75:5034-5034
Imprime PGG is a soluble yeast-derived β-glucan immunomodulator being developed for treatment of cancer in combination with anti-tumor antibodies (Abs). Imprime PGG binds to complement receptor (CR)3 on innate immune cells (neutrophils and monocytes